NCT00361153 Effects on Colesevelam HC1 (WelChol®) on Insulin Sensitivity in Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT00359762 Exenatide Versus Glimepiride in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00358124 Insulin Glargine v Rosiglitazone as add-on Therapy in Patients Failing Sulfonylurea and Metformin Combination Therapy Status COMPLETED Phase PHASE4
NCT00353834 The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT00353691 Glimepiride vs Metformin as Monotherapy in Pediatric Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT00350779 Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052) Status COMPLETED Phase PHASE3
NCT00349427 A Study Of Rosiglitazone Plus Insulin To Treat Type 2 Diabetes Mellitus Patients Status COMPLETED Phase PHASE3
NCT00335712 Pilot Study of ONO-5129 in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT00334503 Open Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide Status COMPLETED Phase PHASE3
NCT00334399 Double-Blind Trial of Miglitol in Type 2 Diabetic Patients Treated With Biguanide Status COMPLETED Phase PHASE3
NCT00330330 Safety, Tolerability, and Activity of ISIS 113715 in People With Type 2 Diabetes Mellitus Who Have Not Received Prior Treatment Status COMPLETED Phase PHASE2
NCT00330200 Effects of ISIS 113715 on Insulin Sensitivity, Glucose, and Lipid Metabolism and Energy Expenditure in Type 2 Diabetics Status TERMINATED Phase PHASE2
NCT00328627 Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus. Status COMPLETED Phase PHASE3
NCT00328536 Omacor for the Treatment of Vascular Dysfunction in Patients With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE4
NCT00327626 Safety, Tolerability, and Activity of ISIS 113715 in People With Type 2 Diabetes Mellitus Being Treated With Sulfonylurea Status WITHDRAWN Phase PHASE2
NCT00324363 Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformin Status COMPLETED Phase PHASE3
NCT00318032 A Study to Investigate the Benefits of the Early Detection and Intensive Treatment of Type 2 Diabetes Status UNKNOWN Phase NA